Loading provider…
Loading provider…
Urology Physician in Los Angeles, CA
NPI: 1356578066Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Urology Associates
uclahealth.org
HQ Phone
Get MD, PHD Arnold's Phone Numberphone_androidMobile
Get MD, PHD Arnold's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2005 - 2027
CA State Medical License

American Board of Urology
Urology
UCLA David Geffen School of Medicine/UCLA Medical Center
Residency • Urology
2005 - 2009
Residency • Surgery
2003 - 2005
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 2003
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 177 | 224 |
| 2 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 107 | 152 |
| 3 | 81002Urinalysis, manual test | 77 | 167 |
| 4 | 51798Ultrasound measurement of bladder capacity after voiding | 70 | 88 |
| 5 | 99212Established patient outpatient visit, total time 10-19 minutes | 58 | 79 |
Involvement of receptor-interacting protein 2 in innate and adaptive immune responses
Authors: Chin, Arnold I, Dempsey, Paul W, Bruhn, Kevin, Miller, Jeff F, Xu, Yang, Cheng, Genhong
Journal: Nature
Transverse vaginal septum with congenital vesical-vaginal communication and cyclical hematuria.
Authors: Shlomo Raz, Matthew Rutman
Journal: Urology
Authors: Chin, A I, Shu, J, Shan Shi, C, Yao, Z, Kehrl, J H, Cheng, G
Journal: Mol Cell Biol
Lead Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: Merck Sharp & Dohme LLC
Intervention / Treatment: DRUG: Carboplatin, DRUG: Docetaxel, BIOLOGICAL: Pembrolizumab, DRUG: Cisplatin, DRUG: Etoposide